Pentazocine Hydrochloride And Naloxone Hydrochloride 00591-0395
Product NDC
00591-0395- Manufacturer
- Actavis Pharma, Inc.
- Dosage Form
- Tablet
- Product Type
- Drug For Further Processing
- DEA Schedule
- Schedule CIV
- Marketing Start
- September 16, 2015
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Naloxone Hydrochloride | .5 mg/1 |
| Pentazocine Hydrochloride | 50 mg/1 |
Packaging Options(2)
45460 TABLET in 1 BOX (0591-0395-00)
54552 TABLET in 1 CONTAINER (0591-0395-77)
External Resources